Dabur India Limited — PPTs, 30-01-2025: Investor Presentation

**Q3 FY25 Financial Highlights:**

Dabur India reported a consolidated revenue from operations of ₹3,355 Cr, marking a 3.1% year-on-year growth. Operating profit stood at ₹682 Cr, down slightly from 20.5% to 20.3% as a percentage of revenue, while net profit saw a minimal increase to ₹522 Cr. Key contributors to growth include the Home & Personal Care segment, which saw a 9.1% rise, and the Foods division, which jumped by 30%. In international markets, revenue reached ₹847 Cr with an impressive 18.9% growth.

**Strategic Initiatives and Growth Drivers:**

The company maintains a strong focus on rural markets that outperformed urban areas for the fourth consecutive quarter, benefiting from enhanced distribution strategies. Notable brand campaigns featuring celebrities are aimed at improving visibility and market share in critical segments.

**Business Developments:**

Dabur seeks to enhance its product portfolio, particularly in health supplements, and is focusing on expanding its international footprint. The company highlights growth in various regions, including significant contributions from Egypt and Turkey.

**Market Position and Competitive Advantage:**

Dabur's competitive edge stems from its strong brand recognition and market leadership, particularly in core categories like healthcare and personal care. The company continues to innovate with science-backed claims and functional product offerings.

**Investor Implications:**

Overall, Dabur's steady growth trajectory and strategic initiatives suggest a positive outlook for investors, despite challenges in certain volume-driven categories. Close attention to operational execution and market conditions will be critical for sustaining performance.